U.S. Healthtech Stock News

On 24 February 2026, ControlPlane and Check Point Software Technologies announced a collaboration to provide a regulator-ready security framework for enterprises adopting Large Language Models and agentic AI systems at scale. A key proof point is deployment of Check Point’s AI security platform in a highly regulated financial institution handling over three million AI prompts daily, showing how the partnership can support stringent governance without slowing development. We’ll now examine...

Fresh inflation data and a 0.5% rise in the Producer Price Index have put credit risk back in focus for regional lenders, with FirstSun Capital Bancorp (FSUN) trading amid heightened concern about problem loans. See our latest analysis for FirstSun Capital Bancorp. Beyond the fresh inflation shock, FirstSun Capital Bancorp’s pending merger with First Foundation and its share price of $37.12 frame a mixed picture. The 90 day share price return of 9.89% contrasts with a 1 year total shareholder...

Pagaya Technologies (NasdaqCM:PGY) is shifting its business model toward an asset-light AI infrastructure approach. The company is pivoting away from riskier segments and focusing on partnering with major banks and fintechs. Its technology is being used in areas such as prime loans and buy now, pay later services with established financial institutions. Pagaya sits at the intersection of finance and data science, providing AI-driven infrastructure that helps banks and consumer finance...

Recent share performance and what it might signal NIKE (NKE) has been under pressure recently, with the stock down about 2% over the past week and roughly 6% over the past 3 months, while the past year shows a 20% total return decline. Short term weakness sits against a longer multiyear stretch where total returns are also negative. This may prompt you to reassess how the company’s current valuation lines up with its fundamentals and long term brand position. See our latest analysis for...

Arcutis Biotherapeutics (ARQT) is back in focus after a cluster of company updates, including first patient dosing in a Phase 1a/1b study of ARQ-234 for atopic dermatitis and fresh financial guidance. See our latest analysis for Arcutis Biotherapeutics. Despite a 1-day share price return showing an 8.19% decline and a 90-day share price return showing a 15.87% decline to US$24.76, Arcutis Biotherapeutics still shows a 1-year total shareholder return of 92.99% and a 3-year total shareholder...

The U.S. administration has moved to pause Halliburton's planned auction of equipment in Venezuela, signaling a possible reopening of the country's oil sector to American firms. This shift in policy could support renewed activity for oilfield services companies, including SLB (NYSE:SLB), as Venezuela explores restarting parts of its oil operations. The development points to potential new demand for services and technology in Venezuela's energy sector that has not yet been widely reflected in...

If you are wondering whether Waste Management's share price still reflects its underlying worth, this article will walk through what the current market price might be implying about value. The stock most recently closed at US$243.07, with returns of 5.4% over 7 days, 9.4% over 30 days, 11.3% year to date, 5.5% over 1 year, 68.9% over 3 years, and 116.0% over 5 years. These figures raise fair questions about how much optimism is now reflected in the price and how risk is being...

Why General Motors stock is on investors’ radar today General Motors (GM) is drawing attention after recent trading left the shares with a 1 day return of 1.21% and a past month return of 7.43%, contrasting with a past 3 months gain of 5.57%. See our latest analysis for General Motors. At a share price of US$77.76, GM has recently seen a 1 day share price decline of 1.21% and a 30 day share price decline of 7.43%. However, its 1 year total shareholder return of 65.82% and 3 year total...

If you are wondering whether Lowe's Companies is still worth considering at around US$257 a share, you are not alone. Many investors are asking if the current price lines up with the underlying value. The stock has seen mixed returns, with a 6.3% decline over the last 7 days and a 3.7% decline over 30 days, but a 4.2% gain year to date and a 6.6% return over 1 year. This adds to a 35.3% 3 year and 73.2% 5 year return backdrop that many long term holders will be weighing carefully. Recent...

Key recent performance signals for Datavault AI Datavault AI (DVLT) has been drawing attention after a difficult past 3 months, with a return of about a 64% decline, while the share price most recently closed at US$0.68. Over the past month the stock shows a small positive return, in contrast with weaker year-to-date and 1-year total returns. This may prompt investors to reassess how they view Datavault AI at current levels. At the business level, Datavault AI reports revenue of US$6.17...

OneSpaWorld Holdings reported past fourth-quarter 2025 revenue of US$242.13 million, up from US$217.21 million a year earlier, while quarterly net income eased to US$12.06 million and long-lived asset impairment charges rose to US$2.97 million. Despite slightly lower profitability, the company reaffirmed its 2026 revenue outlook, maintained a quarterly US$0.05 dividend, and completed a US$37.5 million share repurchase, signaling continued commitment to returning cash to shareholders. Against...

If you are wondering whether Badger Meter is still worth a place on your watchlist after its recent swings, the key question is how its current share price lines up against underlying value. The stock closed at US$152.20 most recently, with returns of 3.8% over 30 days, a 2.6% decline over 7 days, and longer term moves of a 13.7% decline year to date, a 26.8% decline over 1 year, 29.9% over 3 years, and 57.3% over 5 years that may leave investors reassessing risk and return. Recent coverage...

Super Micro Computer (NasdaqGS:SMCI) reported industry validation for its AI optimized server platforms in large scale, automated AI cloud environments. The company highlighted new collaborations with global telecom providers, Mirantis, and energy market operators tied to sovereign AI data center deployments. In a separate grid focused pilot, Supermicro’s AI infrastructure participated in an energy flexibility demonstration that linked data center workloads to real time grid signals. Super...

Northern Trust agreed a new asset servicing mandate with CK Capital Partners, supporting its European fund servicing franchise. The firm is integrating Berenberg's AI based currency hedging models into its offering for asset servicing clients. Northern Trust expanded its collateralized loan obligation middle office services to meet changing institutional client needs in structured credit. Northern Trust, traded as NasdaqGS:NTRS, is moving to widen its role as a global asset servicer, while...

In February 2026, Allegion reported fourth quarter 2025 results showing higher year-over-year sales and net income, and issued full-year 2026 guidance calling for 5% to 7% reported revenue growth, 2% to 4% organic revenue growth, and reported EPS of US$8.00 to US$8.20 (US$8.70 to US$8.90 adjusted). The combination of continued revenue and earnings growth in 2025 alongside higher projected adjusted EPS for 2026 highlights how Allegion is leaning on its mix of security products and solutions...

If you are looking at Clarivate and wondering whether the current price reflects its true worth, this article focuses squarely on what the numbers say about value. The stock last closed at US$2.31, with a 37.5% gain over the past 7 days, but returns sit at a 12.8% decline over 30 days and a 45.1% decline over 1 year, with even larger falls over 3 and 5 years. Recent coverage around Clarivate has largely centered on its position as an information and analytics provider and how investors are...

Quarterly earnings beat sets fresh context for Atkore (ATKR) Atkore (ATKR) recently reported quarterly results that came in ahead of analyst expectations for both earnings per share and EBITDA, with revenue of US$655.5 million modestly above forecasts and roughly in line with last year. See our latest analysis for Atkore. The share price has been relatively muted around US$65.41, with a 1 day share price return of 1.08% and a 1 year total shareholder return of 13.38%. However, the 3 year...

If you are wondering whether Jazz Pharmaceuticals at around US$190 a share is priced attractively or already baking in a lot of expectations, you are in the right place. The stock has shown strong momentum recently, with returns of 9.9% over 7 days, 15.8% over 30 days, 10.0% year to date and 35.8% over the last year, on top of 33.4% and 18.0% over the past 3 and 5 years respectively. Recent news around Jazz Pharmaceuticals has focused on the company as a specialty pharma player and its...

Dana Incorporated has reported past full-year 2025 results showing sales of US$7,500 million, a move from a net loss of US$57 million to net income of US$85 million, and earnings per share turning positive even as revenue eased slightly year over year. Alongside this return to profitability, Dana completed a large share repurchase program that retired 25.38% of its shares for US$653.3 million, meaning recent earnings are being spread across a much smaller shareholder base. We will now...

Ryerson Holding Corporation recently reported fourth-quarter 2025 sales of US$1,104.8 million and a net loss of US$37.9 million, alongside full-year 2025 sales of US$4,571.3 million and a net loss of US$56.4 million, all compared with the prior year. Despite relatively steady annual sales, the company’s loss per share from continuing operations widened materially for both the quarter and full year, while it also completed a share repurchase program that retired 5,847,014 shares since its...

Dole (NYSE:DOLE) just packed several updates into its latest quarter, combining earnings that aligned with expectations, the sale of Ecuador port assets, share buybacks, and its first domestic Form 10-K filing. See our latest analysis for Dole. At a share price of $15.80, Dole’s recent 1-day share price return of a 1.5% decline contrasts with an 8.97% 90 day share price gain and a 3 year total shareholder return of 40.75%, hinting at momentum gradually building as investors weigh earnings,...

The New York State Common Retirement Fund has urged shareholders to vote against the re-election of two Starbucks (NasdaqGS:SBUX) directors. The call targets board members ahead of the company’s upcoming annual meeting. This public stance highlights shareholder dissatisfaction with aspects of Starbucks governance and oversight. Starbucks, known globally for its coffee stores and branded products, sits at the intersection of consumer trends, labor relations, and corporate governance...

Target lost a significant premises liability lawsuit, with a federal jury awarding $2.7 million to an injured customer. The jury found Target fully responsible for a preventable tripping hazard at a Denver area store, resulting in severe and permanent injury. Target did not appeal the verdict, making this a finalized legal outcome with potential implications for store safety practices and risk management. For investors watching NYSE:TGT, this case lands at a time when the stock trades at...

Cushman & Wakefield (NYSE:CWK) is expanding in Florida by adding brokerage and valuation teams to grow its presence in key regional markets. The company has launched an AI Impact Barometer to help clients assess how artificial intelligence affects real estate and the broader built environment. Cushman & Wakefield is a global commercial real estate services firm, and Florida is a major market for offices, industrial properties, housing and logistics. By bringing in new brokerage and...